Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $20.77, for a total value of $83,080.00. Following the completion of the transaction, the vice president directly owned 70,733 shares in the company, valued at approximately $1,469,124.41. This represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Arteris Trading Up 3.3%
Shares of AIP opened at $21.37 on Friday. The firm has a market cap of $1.05 billion, a P/E ratio of -24.56 and a beta of 1.91. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.57 and a quick ratio of 1.57. Arteris, Inc. has a 1 year low of $8.42 and a 1 year high of $50.26. The company has a 50 day simple moving average of $29.78 and a two-hundred day simple moving average of $27.41.
Arteris (NASDAQ:AIP – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%.The company had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. On average, equities analysts expect that Arteris, Inc. will post -0.68 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on Arteris
Hedge Funds Weigh In On Arteris
Institutional investors have recently bought and sold shares of the business. Needham Investment Management LLC grew its stake in shares of Arteris by 2.6% in the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock worth $52,878,000 after buying an additional 86,500 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Arteris during the 2nd quarter valued at about $160,129,000. California State Teachers Retirement System raised its position in shares of Arteris by 105,728.3% during the 2nd quarter. California State Teachers Retirement System now owns 1,807,548 shares of the company’s stock valued at $87,829,000 after buying an additional 1,805,840 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Arteris by 6.2% in the 4th quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company’s stock valued at $27,017,000 after acquiring an additional 101,646 shares during the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of Arteris by 8.2% in the 3rd quarter. Vanguard Group Inc. now owns 1,594,402 shares of the company’s stock valued at $16,103,000 after acquiring an additional 120,947 shares during the last quarter. Institutional investors own 64.36% of the company’s stock.
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Arteris
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
